SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine (Aim Vaccine Co Ltd)

N/A

Report date: 2026/05/13 09:11:25

Base Information

Drug NameSARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine (Aim Vaccine Co Ltd)

Drug Alias NameLVRNA-012

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesAim Vaccine Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAim Vaccine Co Ltd

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A